-
Sign up for our new free newsletters for industry news, insight, and analysis: https://mailchi.mp/xconomy.com/subscribe-twitter-profile …
#Xconomists#XconXpertise#XconBioRoundup#XcelerateLS#XconSD#XconSF#XconNY#XconBOS#XconSEA#XconPHIpic.twitter.com/BW5Oav6cRA
-
Brain and neurological disorders are among the toughest conditions to diagnose and treat, but new approaches and technologies are on the horizon that could change how researchers and clinicians approach them. https://xconomy.com/xpertise/whats-next-neuroscience-therapies/ …
#xconxpertise pic.twitter.com/GUHGxaDnmR
-
New on
#XconXpertise:@Polaryx777 President & CEO Hahn-Jun Lee discusses the company's work accelerating availability of treatment options for underserved neurodegenerative disorder patients, and the scientific rationale behind their products. https://xconomy.com/xpertise/polaryx-therapeutics-lysosome-biogenesis-neurodegenerative-disorders/ …@EBDgroup -
New to
#XconXpertise video: Learn about @Barc_Lab's lab space and network of scientific experts who work with their clients from early development through Phase III trials. https://xconomy.com/xpertise/barc-lab-expanding-globally-bring-personalized-approach-to-more-clients/ …#sponsoredpic.twitter.com/SybPwzKqif
-
New video up on
#XconXpertise: Tools4Patient aims to reduce effect of placebo response in clinical trials with predictive algorithms https://xconomy.com/xpertise/tools4patient-aims-to-reduce-effect-of-placebo-response-in-clinical-trials/ …#sponsoredpic.twitter.com/keT83HgGJP
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.